Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.

On August 17, the FDA approved Mylan’s new generic versions of Actos (pioglitazone), a once-daily oral tablet for the treatment of type 2 diabetes originally sold by...

The Partnership for a Healthier America (PHA) will hold its second Building a Healthier Future Summit from March 6-8, 2013, in Washington, DC. We cannot wait to hear...

Kelly reveals how you can help change the truly unacceptable care people with diabetes are receiving in prison.

Kerri Morrone Sparling reveals how the Internet has built an all new kind of diabetes community.

Michelle Obama at the Partnership for a Healthier America’s Summit.

On World Diabetes Day in San Francisco, Manny Hernandez of the Diabetes Hands Foundation (DHF) announced that the DHF had exceeded its goal to get 20,000 people to take...

In late June, diaTribe sent our team to Chicago to attend the 67th Annual Scientific Sessions of the American Diabetes Association.

Kerri Sparling digs deep and tells us more about why social networking really does matter.

diaTribe salutes director Jennifer Mackenzie for her emerging film Sugar Babies . The documentary examines the impact of type 1 and type 2 diabetes on children in...

Amylin Pharmaceuticals, developer of the GLP-1 agonists Byetta and Bydureon ( recently acquired by Bristol-Myers Squibb ), has pledged to donate $5 to a diabetes charity...

Kelly reflects on some changes here at diaTribe and in the world of diabetes and obesity.

In January, the American Heart Association and American Diabetes Association published a statement giving their joint recommendations for the primary prevention of CVD...

On July 30, Ambio Health announced FDA clearance of its Remote Health Monitoring System , which can wirelessly send readings from the AgaMatrix Presto blood glucose...

On November 22, J&J/Janssen Cilags’ SGLT-2 inhibitor Invokana (canagliflozin) was approved in Europe. This makes Invokana the second SGLT-2 inhibitor approved in...

On April 15, the FDA approved GlaxoSmithKline’s once-weekly GLP-1 agonist Tanzeum (albiglutide) for type 2 diabetes, which makes it the second once-weekly GLP-1 agonist...

At the recent 2013 European Association for the Study of Diabetes (EASD) conference, Abbott debuted a new diabetes technology category called Flash Glucose Monitoring...

(S)he said what!?

On January 21, Glooko and Joslin announced a partnership to develop a new web/mobile-based diabetes management platform. The system will combine a “Virtual Joslin”...

Six inspiring lessons learned over the last decade at the Behavioral Diabetes Institute.